Physical and Chemical Compatibility

Compatibility is broader than drug-to-drug mixing

Compatibility means the components can safely remain together for the required time under the planned conditions. The CSPT outline lists medications, ingredients, base solutions, filters, tubing, and closures, so the check extends beyond the active drug. A drug that is perfectly stable by itself can still be incompatible with the diluent, the bag plastic, the in-line filter, or another drug sharing the same line.

Physical versus chemical compatibility

Physical incompatibility is often visible during compounding or final inspection. Chemical incompatibility may not be visible at all — a clear, colorless bag can have lost half its drug to hydrolysis. That invisibility is why references and pharmacist review matter when drugs, diluents, containers, or administration devices change.

Component interactions to watch

• Adsorption / sorption: A drug can bind to PVC tubing, filters, or plastic containers, leaving less active medication for the patient. Classic examples: insulin and nitroglycerin adsorb to PVC, so non-PVC (polyolefin/glass) sets are preferred.
• Leaching: DEHP (di-2-ethylhexyl phthalate) plasticizer can leach out of PVC into lipid-containing solutions (lipid emulsions, taxanes), so non-DEHP sets are used.
• Filter retention: A filter removes particles as intended, but it can also retain drug. Liposomal and emulsion products and some monoclonal antibodies must not be filtered, or require a specific micron rating.
• pH mismatch: Mixing an acidic drug with a basic one can precipitate or degrade either. Check the formulation pH against the diluent.

Calcium-phosphate precipitation in PN

Calcium and phosphate in parenteral nutrition (PN) are the classic exam compatibility hazard. Insoluble calcium phosphate crystals can form and, if infused, cause fatal pulmonary emboli. Risk rises with higher calcium and phosphate concentrations, higher pH, higher temperature, and adding calcium before the phosphate is well diluted. Defenses: add phosphate early and calcium last; use calcium gluconate (not chloride), which dissociates less; keep concentrations within validated limits; and use an in-line filter (0.22-micron for non-lipid 2-in-1, 1.2-micron for lipid-containing 3-in-1).

Practical exam workflow

Before compounding, verify the drug, diluent, concentration, container, route, storage condition, and administration device against approved references or facility policy. During compounding, stop for unexpected cloudiness, crystals, gas, color change, leaking, or container defects.

At final inspection, compare the preparation against the order and expected appearance. Do not try to solve unexplained compatibility findings by shaking, filtering, warming, relabeling, or shortening the BUD on your own — those actions can hide an unsafe product. Hold the CSP, quarantine it, and escalate to the pharmacist per policy.

Common incompatibility examples to recognize

Diluent matching and order of mixing

The right diluent is part of compatibility. Some drugs precipitate or degrade in dextrose (D5W) but are fine in normal saline (0.9% NaCl), and vice versa. When an order specifies a diluent that conflicts with the package insert, the technician confirms before proceeding rather than substituting silently. A common exam scenario gives a drug stable only in D5W with an order written for NS — the correct action is to hold and clarify, not to swap on your own.

For complex admixtures (especially PN), the order of addition changes the outcome even when the final ingredient list is identical. Adding two reactive ions at high local concentration before the volume is built up drives precipitation; sequencing additions and mixing thoroughly between them keeps concentrations low at every step. This is why facility-validated mixing sequences and automated compounders exist, and why the exam rewards "follow the validated sequence" over "all ingredients end up in the bag anyway."

Final visual inspection checklist

Every finished CSP gets a deliberate look against light and a dark background before release. Reject or hold the preparation if you see any of the following:

• Particulates, fibers, crystals, or precipitate
• Cloudiness or haze in what should be a clear solution
• Unexpected color change versus the expected appearance
• Gas bubbles or effervescence after mixing
• Cracked lipid emulsion (oil droplets separating or a yellow-brown layer)
• Container leaks, swelling, or coring fragments from the stopper

The absence of a visible problem does not prove chemical compatibility — it only rules out gross physical incompatibility. That is the core lesson: visible checks catch physical problems, while references and pharmacist review catch the invisible chemical ones. A technician who relies only on "it looks fine" will miss potency loss and degradation the CSPT specifically tests.